Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-28.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -771.05% |
| Q2 2025 | 92.23% |
| Q1 2025 | -124.76% |
| Q4 2024 | 59.51% |
| Q3 2024 | -129.14% |
| Q2 2024 | -145.31% |
| Q1 2024 | 9.95% |
| Q4 2023 | 232.21% |
| Q3 2023 | 69.77% |
| Q2 2023 | 2.56% |
| Q1 2023 | -185.08% |
| Q4 2022 | -16.78% |
| Q3 2022 | 70.09% |
| Q2 2022 | -180.17% |
| Q1 2022 | 65.96% |
| Q4 2021 | -305.62% |
| Q3 2021 | -230.67% |
| Q2 2021 | 47.87% |
| Q1 2021 | 58.66% |
| Q4 2020 | -20.92% |
| Q3 2020 | 27.39% |
| Q2 2020 | -31.52% |
| Q1 2020 | -70.89% |
| Q4 2019 | -40.89% |
| Q3 2019 | -1725.95% |
| Q2 2019 | -124.55% |
| Q1 2019 | 282.71% |
| Q4 2018 | -407.37% |
| Q3 2018 | -96.89% |
| Q2 2018 | -62.03% |
| Q1 2018 | 3203.49% |
| Q4 2017 | -77.31% |
| Q3 2017 | -12.48% |
| Q2 2017 | -29.94% |
| Q1 2017 | 163.95% |
| Q4 2016 | -59.96% |
| Q3 2016 | -29.96% |
| Q2 2016 | 122.32% |
| Q1 2016 | -1234.37% |
| Q4 2015 | -36.72% |